Which company develops and produces Dacomitinib?

Dacomitinib (Dacomitinib) is a targeted therapy drug developed and produced by Pfizer Inc. (Pfizer Inc.). Pfizer is one of the world's leading pharmaceutical companies, developing and delivering innovative medical solutions that improve patients' health and quality of life.

The development of dacomitinib began in the early 20 century, with the development of non-small cell lung cancer (NSCLC) and epidermal growth factor receptor ( EGFR) mutation mechanism, Pfizer began to explore the development of second-generation EGFR tyrosine kinase inhibitors. Dacomitinib shows significant therapeutic potential by inhibiting EGFRkinase activity, especially for EGFR mutation-positive NSCLC patients.

In the clinical trial phase,Dacomitinib (dacomitinib) has shown good efficacy and safety in multiple studies. Particularly in the ARCHER 1050 trial, dacomitinib significantly prolonged patients’ progression-free survival (PFS) and significantly reduced the risk of disease progression or death compared with standard treatment. These research results laid the foundation for the approval and marketing of dacomitinib (dacomitinib).

Based on the positive results of clinical trials, Dacomitinib (dacomitinib) has been approved by drug regulatory agencies in many countries and regions around the world, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These approvals mark the official entry of Dacomitinib (Dacomitinib) into the market, providing a new treatment option for patients with EGFR mutation-positive non-small cell lung cancer.

Dacomitinib (Dacomitinib)As a targeted therapy drug, it is mainly used to treat EGFREGFRMutation-positive non-small cell lung cancer. Its unique mechanism of action enables it to show significant efficacy in the treatment of osimertinib-resistant patients. Dacomitinib (Dacomitinib) blocks the growth and spread of cancer cells by inhibiting EGFR kinase activity, providing patients with longer progression-free survival and improved quality of life.